Dr John Pimanda is a clinical hematologist at the Prince of Wales Hospital, and Professor of Medicine and stem cell biology at the UNSW Lowy Cancer Research Centre in Sydney, Australia, where he runs a research program focussed on developing new strategies to improve patient outcomes in MDS. His work involves a pipeline of research where tissue samples are collected from patients with known clinical response to drugs to perform laboratory research to identify mechanisms of resistance and response. Discovery of new drug targets and combinations are subsequently evaluated in investigator initiated clinical trials with suitable industry and clinical partnerships. He is the recipient of a Leukemia Lymphoma Society-Snowdome Foundation-Leukaemia Foundation (LLS-SF-LF) Translational Research Project grant to identify new drug targets that improve efficacy of current therapy using chemical genome screening and mouse xenografts carrying MDS patient blood stem cells.